Table 3.

Most important characteristics of rehabilitation programmes’ beneficiaries.

Characteristics	Details	N (%)*
Participants’ sex predominance
	Female predominance	122 (43.1)
	Balanced	90 (31.8)
	Male predominance	55 (19.4)
	Not reported	16 (5.7)
Target population
	People with a single health condition	167 (59.0)
	People with a decline in functioning/functional ability**	99 (34.9)
	People with more than two health conditions	17 (6.0)
Health condition area
	Neurological	59 (33.9)
	Cardiovascular	39 (22.4)
	Musculoskeletal	34 (19.5)
	Respiratory	16 (9.2)
	Cancer	7 (4.0)
	Metabolic	6 (3.5)
	Communicable diseases	5 (2.9)
	Pain	3 (1.7)
	Autoimmune diseases	2 (1.2)
	Sensory	2 (1.2)
	Urological	1 (0.6)
Health condition
	Stroke	41 (23.3)
	Chronic obstructive pulmonary disease	16 (9.1)
	Hip fracture or post hip arthroplasty	16 (9.1)
	Heart failure	13 (7.4)
	Coronary heart disease	12 (6.8)
	Cardiovascular disease not specified	11 (6.3)
	Cognitive impairment	11 (6.3)
	Osteoarthritis	10 (5.7)
	Breast cancer	4 (2.3)
	COVID-19	4 (2.3)
	Diabetes	4 (2.3)
	Others***	34 (19.4)

^*Represents the proportion of included studies.

^**Parkinson’s disease, Multiple Sclerosis, other neurological diseases not specified, Peripheral Artery Disease, chronic pain, Complex Regional Pain Syndrome, degenerative scoliosis, low back pain, rotator cuff tendinopathy, lower limb amputation, distal radius fracture, other fractures or injuries not specified, prostate cancer, lung cancer, lymphoma, other cancers not specified, sarcopenia, chronic kidney disease, Diffuse Cutaneous Systemic Sclerosis, inflammatory arthritis, vestibular dysfunction, vision impairment and, Human Immunodeficiency Virus. COVID-19: Coronavirus disease 2019.

^***Include those with a unspecified decline in functioning/functional ability, fragility, or sarcopenia.